We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type

9 results found


Hogan Lovells | USA | 8 Jul 2017

House Subcommittee on Health Opens Floor for Discussion of FDA Regulation of Off-Label Speech

The House Subcommittee on Health has announced a hearing entitled “Examining Medical Product Manufacturer Communications” for Wednesday, July 12, 2017


Hogan Lovells | USA | 1 Jun 2017

FDA Begins Reorganization that Will Affect How it Regulates Medical Technology

The U.S. Food and Drug Administration (FDA) has undertaken significant reorganization efforts this year that affect the way it regulates medical


Hogan Lovells | USA | 24 Apr 2008

Congress requests information for pending biosimilar legislation

In an effort to reach consensus on proposed legislation regarding follow-on biologic (FOB) products, Congress recently issued a letter to biotechnology companies, trade associations, and governmental agencies requesting highly specific information and feedback on the issues surrounding the approval of FOB products.

Previous page 1 Next page